1. Home
  2. |Insights
  3. |Advanced EC Competition Law 2009 - An advanced review of the major developments in EC competition law and policies

Advanced EC Competition Law 2009 - An advanced review of the major developments in EC competition law and policies

Event | 11.18.09 - 11.19.09, 12:00 AM UTC - 12:00 AM UTC

IBC’s 18th highly acclaimed annual conference Advanced EC Competition Law in Brussels provides participants with a unique in-depth update on the major developments in competition law and policy over the past twelve months.

This 2009 competition law review will cover a wide range of topics. The final report on the pharmaceutical sector inquiry, the ongoing review of vertical; restraints as well as recent and expected developments in cartels, mergers and Article 82 will be debated lively by officials from the Commission, practitioners, in-house counsel and economists.

Key areas of focus:

  • Review of major events and policy issues 2008 - 2009 - State aid
  • Pharmaceutical sector enquiry – the Final Report - The ongoing review of vertical restraints
  • The Commission's priorities and future policies - Key developments in Article 82
  • Cartels
  • Merger control
  • Mergers and joint ventures

Sean-Paul Brankin is part of a panel at this event.

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.